Rachael Beairsto

Editor ttps://www.thecardiologyadvisor.com

Rachael Beairsto is a medical editor with Haymarket Media, Inc, overseeing all things related to hormone health at Endocrinology Advisor. She holds a BS in biology from Northeastern University in Boston, Massachusetts. Prior to joining Haymarket in 2018, Rachael worked at Ogilvy in a healthcare communications role and at Sanofi in a market research group supporting the marketing of established medications within the biosurgery and renal disease spaces.

All articles by Rachael Beairsto

General Cardiology

“Cardiabetes”: Is It Time for a New Subspecialty?

Rachael Beairsto

July 18, 2019

With a growing number of patients with both diabetes and cardiovascular disease, clinicians consider the need for a new specialty: cardiometabolic medicine.

Stroke

Low Rates of Osteoporosis Screening After Stroke Despite Increased Fracture Risk

Rachael Beairsto

April 26, 2019 1:05 am

Rates of osteoporosis screening and treatment are low in patients with recent stroke despite elevated risk for low-trauma fracture.

medical professional drawing blood from child

Dyslipidemia

High Rates of Abnormal Glucose, Dyslipidemia Found in Middle School Students

Rachael Beairsto

March 19, 2019

Researchers found high rates of dyslipidemia and abnormal HbA1c, including 2 cases of diabetes, after screening for cardiovascular risk factors in middle school students.

ACC 2019 Meeting Highlights

Canagliflozin Reduces Heart Failure Risk in T2D With Preserved EF

Rachael Beairsto

March 18, 2019

Canagliflozin reduced the risk for heart failure in the context of both reduced EF and preserved EF.

ACC 2019 Meeting Highlights

SGLT2 Inhibitors Reduce Heart Failure Risk in T2D With Reduced EF

Rachael Beairsto

March 15, 2019

Real-world data indicate that lower risk of heart failure hospitalization and death associated with use of sodium-glucose cotransporter-2 inhibitors is consistent in patients with T2D with both reduced and preserved ejection fraction.

Dyslipidemia

Adherence to Statin Guideline Recommendations Vary Widely in US Clinics

Rachael Beairsto

March 15, 2019

Clinics in the United States varied widely in their adherence to statin recommendations, which was associated with wide differences in low-density lipoprotein cholesterol control.